EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in nonsmall cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1123-1128

Science Publishers

Access to resources Recommend Favorite

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study

By            

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 299-305

Spandidos Publications

Access to resources Recommend Favorite

Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy

By                    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3523-3532

Spandidos Publications

Access to resources Recommend Favorite

Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis

By                

Experimental and Therapeutic Medicine, Vol. 7, Iss. 6, 2014-01 ,pp. : 1578-1582

Spandidos Publications

Access to resources Recommend Favorite

Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy

By Wang Lei   Meng Long   Wang Xing-wen   Ma Guo-yuan   Chen Jing-han  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 1899-1906

Springer Publishing Company

Access to resources Recommend Favorite